CAR T-cells for colorectal cancer immunotherapy: Ready to go?

Chimeric antigen receptor (CAR) T-cells represent a new genetically engineered cell-based immunotherapy tool against cancer. The use of CAR T-cells has revolutionized the therapeutic approach for hematological malignancies. Unfortunately, there is a long way to go before this treatment can be develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazi, Bouchra, El Ghanmi, Adil, Kandoussi, Sarah, Ghouzlani, Amina, Badou, Abdallah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705989/
https://www.ncbi.nlm.nih.gov/pubmed/36458008
http://dx.doi.org/10.3389/fimmu.2022.978195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705989/
https://www.ncbi.nlm.nih.gov/pubmed/36458008
http://dx.doi.org/10.3389/fimmu.2022.978195

Ejemplares similares